1. Home
  2. CTMX vs CABO Comparison

CTMX vs CABO Comparison

Compare CTMX & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.39

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$117.93

Market Cap

603.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
CABO
Founded
2008
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
603.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CTMX
CABO
Price
$4.39
$117.93
Analyst Decision
Strong Buy
Hold
Analyst Count
6
3
Target Price
$6.50
$126.00
AVG Volume (30 Days)
2.8M
134.6K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
2.52%
EPS Growth
50.22
N/A
EPS
0.24
N/A
Revenue
$113,631,000.00
$1,524,897,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$96.67
52 Week High
$4.62
$384.11

Technical Indicators

Market Signals
Indicator
CTMX
CABO
Relative Strength Index (RSI) 61.95 41.45
Support Level $3.86 $114.10
Resistance Level $4.37 $138.00
Average True Range (ATR) 0.26 6.36
MACD 0.02 -0.62
Stochastic Oscillator 90.71 16.03

Price Performance

Historical Comparison
CTMX
CABO

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: